TIAP partners with OBIO to open applications for healthtech funding stream
Selected companies will receive up to $200,000 in grant, dilutive funding.
Selected companies will receive up to $200,000 in grant, dilutive funding.
Plus: Clinia secures $10 million and partnership with Telus Health.
American HealthTech was divested by previous owner CPSI.
Good Chemistry’s CEO and team will join SandboxAQ’s simulation teams.
Plus: 23andMe says maybe you should’ve changed your password.
CEO says endorsement from Canada’s largest healthtech player gives Clinia “visa” it needs to catch big US fish.
BenchSci confirmed to BetaKit that it laid off 17 percent of its workforce.
Recipients include Idealist, Maple Bridge, PaceZero, Raven, Relentless, and The51.
AI’s accuracy problem could spell trouble for patients and practitioners.
Plus: The silly things women’s health entrepreneurs hear from male VCs.
Plus: Medtronic’s $738 million acquisition is cancelled.
Vistara sees opportunity post-SVB as bank lenders, VCs pull back.
Plus: AbCellera decimates staff in biotech slump.
Acquisition comes nine months after Ditch Labs secured $3.25 million CAD in seed funding.
The new fund looks to invest in enterprise software and healthtech startups.